These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Double blind study using amantadine hydrochloride in the therapy of Parkinson's disease. Silver DE; Sahs AL Trans Am Neurol Assoc; 1971; 96():307-8. PubMed ID: 4945919 [No Abstract] [Full Text] [Related]
6. Controlled trial of amantadine hydrochloride in Parkinson's disease. Jorgensen PB; Bergin JD; Haas L; Cuningham JA; Morah DD; Pollock M; Robinson RG; Spears GF N Z Med J; 1971 May; 73(468):263-7. PubMed ID: 4932146 [No Abstract] [Full Text] [Related]
7. L-dopa treatment of parkinsonism. Clinical observations on the use of amantadine hydrochloride. Reveno WS; Bauer RB; Rosenbaum H Geriatrics; 1971 Aug; 26(8):61-70. PubMed ID: 5096462 [No Abstract] [Full Text] [Related]
8. Amantadine HCL (Symmetrel) and its relation to Levo-Dopa in the treatment of Parkinson's disease. Schwab RS; England AC Trans Am Neurol Assoc; 1969; 94():85-90. PubMed ID: 4907453 [No Abstract] [Full Text] [Related]
9. A controlled study of the clinical effects of amantadine hydrochloride (Symmetrel). Merrick EM; Schmitt PP Curr Ther Res Clin Exp; 1973 Aug; 15(8):552-8. PubMed ID: 4200529 [No Abstract] [Full Text] [Related]
10. L-dopa and amantadine hydrochloride in Parkinson's disease. Parkes JD; Zilkha KJ; Knill-Jones RP; Clements PJ; Baxter R Int Z Klin Pharmakol Ther Toxikol; 1971 Apr; 4(3):356-60. PubMed ID: 4931417 [No Abstract] [Full Text] [Related]
12. Effect of amantadine on some psychomotor performances in Parkinsonism. A double blind study. Laitinen LV; Vilkki J Ann Clin Res; 1971 Aug; 3(4):207-11. PubMed ID: 4937341 [No Abstract] [Full Text] [Related]
13. [Amantadine therapy in parkinsonism]. Pakkenberg H Ugeskr Laeger; 1973 Jan; 135(3):135-6. PubMed ID: 4685048 [No Abstract] [Full Text] [Related]
14. [Amantadine and dexetimide in the treatment of parkinsonism]. Hakkarainen H; Viukari M Duodecim; 1973 Jul; 89(21):1437-41. PubMed ID: 4586970 [No Abstract] [Full Text] [Related]
15. [Experience in the prolonged use of midantan (amantadine hydrochloride) in parkinsonism]. Man'kovskii NB; Vainshtok AB; Oleinik LI Zh Nevropatol Psikhiatr Im S S Korsakova; 1973; 73(4):524-30. PubMed ID: 4705407 [No Abstract] [Full Text] [Related]
16. [The treatment of parkinsonism with amantadine]. Völler GW Dtsch Med Wochenschr; 1970 Apr; 95(17):934-7. PubMed ID: 5439551 [No Abstract] [Full Text] [Related]
17. Dexbenzetimide in neuroleptic-induced parkinsonism. A double-blind crossover study with a 16-week follow-up. De Smedt R; Rodrigus E; Debandt R; Brugmans J J Clin Pharmacol J New Drugs; 1970; 10(3):207-11. PubMed ID: 4910278 [No Abstract] [Full Text] [Related]
18. [Results of treatment with amantadine hydrochloride in Parkinson's syndrome using psychological test study methods. (Preliminary report)]. Gerstenbrand F; Grünberger J; Oberhummer I Wien Med Wochenschr; 1971 May; 121(19):390-7. PubMed ID: 5559920 [No Abstract] [Full Text] [Related]
19. [Results of treatment with amantadine hydrochloride in Parkinson's syndrome using psychological test study methods. (Preliminary report)]. Gerstenbrand F; Grünberger J; Oberhummer I HNO; 1970 Nov; 18(11):390-7. PubMed ID: 5512006 [No Abstract] [Full Text] [Related]
20. [Treatment of the Parkinson syndrome with amantadine]. Hartmann-von Monakow K Schweiz Med Wochenschr; 1971 Dec; 101(48):1736-9. PubMed ID: 5140093 [No Abstract] [Full Text] [Related] [Next] [New Search]